ClinicalTrials.Veeva

Menu

Effects of Silver Spike Point Therapy on Pelvic Girdle Pain PAIN

R

Riphah International University

Status

Completed

Conditions

Pelvic Girdle Pain

Treatments

Other: Conservative Managment
Device: Silver Spike Point Therapy (SSPT)

Study type

Interventional

Funder types

Other

Identifiers

NCT05355220
REC/Lhr/22/0506 Maida

Details and patient eligibility

About

The aim of this study is to determine the effects of Silver Spike Point Therapy (SSPT) therapy on pelvic girdle pain and functional activities in pregnancy.The finding of this study will help to establish the role of SSPT therapy to relieve pelvic girdle pain in pregnant females along with exercises. SSP for pelvic girdle pain management can prove to be a useful method. The findings of this study can play a role to establish more rigorous treatment plans for pelvic girdle pain in the pregnant population in the future.

Full description

This study will be a randomized clinical trial that will investigate the effectiveness of silver spike point therapy and manual therapy in subjects with pregnancy-related pelvic girdle pain. Subjects with pregnancy-related pelvic girdle pain meeting the predetermined inclusion & exclusion criteria will be divided into two groups using the lottery method. Pre-assessment will be done using NPRS and PGPQ as subjective measurements and PSFS as objective measurements. Subjects in one group will be treated with silver spike point therapy and manual therapy, the other will be treated with manual therapy only. Each subject will receive 10 treatment sessions, with 05 treatment sessions per week. Post-treatment reading for NPRS, PGPQ, and PSFS will be recorded after the end of the 10th treatment session. Recorded values will be analyzed for any significant difference between pre and post-treatment values SPSS 21.

Enrollment

26 patients

Sex

Female

Ages

20 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female aged between 20 to 40 years of age
  • Healthy pregnancy
  • 14 to 38 weeks gestation
  • Expecting a singleton fetus
  • 2 out of 3 tests positive for PGP according to European guidelines for
  • pelvic girdle pain"(Posterior pelvic pain provocation (P4), Patrick's Faber, Modified Trendelenburg's test)

Exclusion criteria

  • High-risk pregnancy, Caudaequina Syndrome, Trauma, or spinal surgical history.
  • Inflammatory, infective, metabolic, neoplastic, or degenerative conditions.
  • Sensory symptoms associated with disc herniation or compressive spinal lesion.
  • Any contraindication to exercise.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

26 participants in 2 patient groups

silver spike point Therapy Group
Experimental group
Description:
One group will receive electrotherapy (silver spike point) for 10 mints along with conservative managment
Treatment:
Device: Silver Spike Point Therapy (SSPT)
Conservative treatment group
Active Comparator group
Description:
2nd group will receive strengthening, stretching and stabilization exercises for prlvic girlde
Treatment:
Other: Conservative Managment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems